Nitto Denko Avecia Inc., a prominent player in the biotechnology and pharmaceutical sectors, is headquartered in the United States. Founded in 1998, the company has established itself as a leader in contract development and manufacturing, specialising in advanced drug delivery systems and biologics. Avecia operates primarily in North America and has expanded its reach into key global markets. The company is renowned for its innovative core products, including plasmid DNA and viral vectors, which are pivotal in gene therapy and vaccine development. Avecia's commitment to quality and regulatory compliance has positioned it as a trusted partner for biopharmaceutical companies. With a strong focus on research and development, Nitto Denko Avecia Inc. continues to achieve significant milestones, solidifying its reputation in the competitive landscape of biomanufacturing.
How does Nitto Denko Avecia Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Nitto Denko Avecia Inc.'s score of 44 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nitto Denko Avecia Inc., headquartered in the United States, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is committed to climate action, with near-term targets established as part of its sustainability initiatives. These commitments are cascaded from its parent company, Nitto Denko Corporation, which is actively involved in climate-related initiatives. Nitto Denko Avecia Inc. has not set a net-zero target but is classified as "Committed" to near-term targets, reflecting its intention to address its carbon footprint. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, which is increasingly focused on reducing environmental impacts. As part of its climate strategy, Nitto Denko Avecia Inc. aligns with broader corporate sustainability goals, inheriting initiatives from Nitto Denko Corporation, which includes participation in the Science Based Targets initiative (SBTi). This relationship underscores the company's commitment to improving its environmental performance, although specific reduction targets or achievements have not been disclosed. In summary, while Nitto Denko Avecia Inc. does not provide specific emissions data, it demonstrates a commitment to climate action through its alignment with parent company initiatives and a focus on sustainability within its operational framework.
Access structured emissions data, company-specific emission factors, and source documents
| 2003 | 2006 | 2007 | 2008 | 2009 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 340,860,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - |
| Scope 2 | 1,112,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - |
| Scope 3 | 31,186,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | - | - | - | - | - | - | - | - | - | 000,000,000 | - | - | - |
Nitto Denko Avecia Inc.'s Scope 3 emissions, which increased significantly last year and increased significantly since 2003, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 60% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 66% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Nitto Denko Avecia Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.